Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 1013

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 13
Chunk 1013
---
1 to the Company’s Form 10-K filed with the SEC on September
29, 2025

    23.1* 
     
    Consent of Sadler, Gibb & Associates 

    31.1* 
     
    Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934

    31.2* 
     
    Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934

    32.1** 
     
    Certification of Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350

    32.2**
     
    Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350

    97.1
     
    Clawback Policy
     
    Incorporated herein by reference to as Exhibit 97.1 to the Company’s Form 10-K filed with the SEC on October 10, 2024

    101.INS 
     
    XBRL Instance Document* 

    101.SCH 
     
    XBRL Taxonomy Extension Schema* 

    101.CAL 
     
    XBRL Taxonomy Extension Calculation Linkbase* 

    101.DEF 
     
    XBRL Taxonomy Extension Definition Linkbase* 

    101.LAB 
     
    XBRL Taxonomy Extension Label Linkbase* 

    101.PRE 
     
    XBRL Taxonomy Extension Presentation Linkbase* 

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) *

    *
     
    Provided herewith.
  
    **
     
    Furnished herewith.

68

SIGNATURES

Pursuant to the requirements of
Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

    Date: September 29, 2025
    L